KG

Kumarswamy Gubbi Rudrappa

Active Director Director DIN 09102467
DIN 09102467 First appointment Mar 2021 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumarswamy Gubbi Rudrappa

Data last updated:

Kumarswamy Gubbi Rudrappa is a Director at Indo Nutraceuticals Private Limited (since 2021). The company operates in Healthcare.

DIN 09102467
Primary Designation Director
Industry Healthcare
First Appointment 11 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indo Nutraceuticals Private Limited U33100KA2021PTC145203
Director11 Mar 20212021Active

Board colleagues of Kumarswamy Gubbi Rudrappa

NameDINCompanyDesignation
Savitha09102468Indo Nutraceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indo Nutraceuticals Private Limited
Premium access

Shareholding and investment profile for Kumarswamy Gubbi Rudrappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumarswamy Gubbi Rudrappa

Kumarswamy Gubbi Rudrappa currently holds 1 directorship: Indo Nutraceuticals Private Limited (Director, since 11 Mar 2021).

Kumarswamy Gubbi Rudrappa was first appointed on 11 Mar 2021 as Director at Indo Nutraceuticals Private Limited.

The current boards of Kumarswamy Gubbi Rudrappa's companies include Savitha (Indo Nutraceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available